Article
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
The Journal of clinical investigation - 1 Sept 2008
Hacein-Bey-Abina Salima, Garrigue Alexandrine, Wang Gary P, Soulier Jean, Lim Annick, Morillon Estelle, Clappier Emmanuelle, Caccavelli Laure, Delabesse Eric, Beldjord Kheira, Asnafi Vahid, MacIntyre Elizabeth, Dal Cortivo Liliane, Radford Isabelle, Brousse Nicole, Sigaux François, Moshous Despina, Hauer Julia, Borkhardt Arndt, Belohradsky Bernd H, Wintergerst Uwe, Velez Maria C, Leiva Lily, Sorensen Ricardo, Wulffraat Nicolas, Blanche Stéphane, Bushman Frederic D, Fischer Alain, Cavazzana-Calvo Marina
Abstract excerpt
Previously, several individuals with X-linked SCID (SCID-X1) were treated by gene therapy to restore the missing IL-2 receptor gamma (IL2RG) gene to CD34+ BM precursor cells using gammaretroviral vectors. While 9 of 10 patients were successfully treated, 4 of the 9 developed T cell leukemia 31-68 months after gene therapy. In 2 of these cases, blast cells contained activating vector insertions near the LIM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
